about
Neonatal sepsis due to coagulase-negative staphylococciCan we control all-cause meningococcal disease in Europe?Whither vaccines?Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast.Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.Gene expression profiles are different in venous and capillary blood: Implications for vaccine studies.Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study.Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya.An observational study of children with sickle cell disease in Kilifi, Kenya.ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial.Challenges and progress in the development of a serogroup B meningococcal vaccine.How best to describe the risk of meningococcal B infection?Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis.Long-term survival and outcome in children admitted to kilifi district hospital with convulsive status epilepticus.Serogroup B meningococcal vaccines-an unfinished story.Opa proteins and CEACAMs: pathways of immune engagement for pathogenic Neisseria.Bacterial meningitis in childhood.The role of the immune system in governing host-microbe interactions in the intestine.Subacute osteomyelitis of the femur due to Fusobacterium nucleatum in a 7-year-old boy.30-year trends in admission rates for encephalitis in children in England and effect of improved diagnostics and measles-mumps-rubella vaccination: a population-based observational study.The Influence of Maternally Derived Antibody and Infant Age at Vaccination on Infant Vaccine Responses : An Individual Participant Meta-analysis.The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials.Symptomatic stroke complicating central skull base osteomyelitis following otitis media in a 2-year old boy: Case report and review of the literature.Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.Maternal immunisation: collaborating with mother nature.Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation.Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study.A humanized microbiota mouse model of ovalbumin-induced lung inflammation.Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.Anti-N-Methyl-D-Aspartate Receptor Encephalitis In A Young Child With Histological Evidence On Brain Biopsy Of Coexistent Herpes Simplex Virus Type 1 Infection.Brain Abscesses Due to Aspergillus nidulans Infection During Induction Chemotherapy for Acute Lymphoblastic Leukemia.Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study.Childhood meningitis in the conjugate vaccine era: a prospective cohort study.
P50
Q26824171-AA0E2947-7031-4114-9172-F5F2EE8B5827Q30251477-FCFB4ABD-7017-49B0-8C5D-EA5A406AA4FEQ30829948-F20871B5-CF3D-4784-93DD-74E4086E6D53Q34516060-4D3FE51B-7A37-4423-9BB6-DFD3B213C322Q34783257-232656D2-7775-4C32-AB1A-EE5662FD4E52Q34992158-F95CD4C4-978D-4E9F-99B6-13ED1C56C54AQ35328649-E05F4B1B-728D-4699-8918-B01C33121076Q35922195-64835B63-85B0-4854-BF1E-FA85EF98BAE2Q35949585-BDFBA73E-2004-41B5-8515-8A4B39D53976Q35998399-EA7392F0-39DD-4D70-8181-0A8E8811B814Q36136877-43850348-E7C6-492A-AD48-2CF4607FA4B4Q36482379-AEAA8C67-B28F-47EB-B077-976C3F42BAE1Q37306760-0C0C9081-E017-4772-83A8-46D40EB0D401Q37413923-8CDE74C7-5040-4AC9-B380-D042DAB5E723Q37454862-9C295E3E-52D8-4A5E-9218-8A17D82A1CC2Q37503243-2E2301BB-374C-4C6D-AE20-0961F4832675Q37533955-0A9F5D37-C736-45C3-8247-2886FAF104BEQ37545048-680D3FC5-4AE4-4813-96A9-CABC8D7C3958Q37590858-DD63D432-3D93-4E89-8776-02E1B88F8456Q37592668-CB0D3FD8-4F15-43D9-9D9D-2724476974E7Q37683962-0E6A21CF-BA2D-4687-B3D4-725C2DEF89A1Q37825922-22D465D5-FE6F-4B59-ADDA-27CECDFAF25CQ37962444-A46B6C3A-BED4-41BA-BB7E-CDEC17E25AD0Q38115440-D86C386F-D772-4672-A898-8024CA0819E5Q38367923-4ACA5EC4-AAB6-43C0-9934-803B5975DEB2Q38402388-51CF59B6-8C16-4026-A922-3A15D74FC4F4Q38785828-FD815E78-8A33-4F1D-97D2-F453658377A7Q38878868-51E2A0B5-EE91-41EB-B36C-AE01A54AD748Q38952213-2F2D964B-78E2-4992-BAA8-D51BA2EA34E1Q39256577-B18810EE-D223-4967-A784-0631AAA32610Q39256585-CA3D243A-E99D-4960-92DD-D40D5CD50742Q39418716-60DFDE4C-CCAC-4308-AA85-C1206F50D331Q39487823-915143E0-8B18-4407-9270-10FC93B6A396Q39821513-E743109E-AD9D-4D2D-8A8F-E32E45C723B0Q40100993-99ABA5D4-1C66-4246-83B9-73AC15469BDEQ40179042-9ADEDFCE-28A1-4B21-9A62-BD0999B30649Q40874615-2E7ADC36-FE3C-4B66-BE48-35D6084047DFQ41222730-E9AE77ED-810F-46E8-9174-F6F36436B82FQ41531696-BD7024A1-C0D3-4C35-B1A2-933026BAC119Q41726188-8FBA333E-6E0F-49AF-8822-2324A74839FE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manish Sadarangani
@ast
Manish Sadarangani
@en
Manish Sadarangani
@es
Manish Sadarangani
@nl
Manish Sadarangani
@sl
type
label
Manish Sadarangani
@ast
Manish Sadarangani
@en
Manish Sadarangani
@es
Manish Sadarangani
@nl
Manish Sadarangani
@sl
prefLabel
Manish Sadarangani
@ast
Manish Sadarangani
@en
Manish Sadarangani
@es
Manish Sadarangani
@nl
Manish Sadarangani
@sl
P106
P21
P31
P496
0000-0002-9985-6452